Evaluation of Liver Stiffness Performance, by FibroScan®, to Detect Elevated Central Venous Pressure (CVP)
Part of paid clinical trials in Los Angeles, California.
- Sponsor
- Echosens
- Study ID
- NCT07222813
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Heart Failure
- Heart Failure - NYHA II - IV
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- FibroScan — DEVICEAt Day 0: 1 FibroScan examination to collect Liver Stiffness Measurement (LSM)
- Right-sided Heart Catheterization — PROCEDUREat Day 0: Right-sided Heart Catheterization (RHC) to measure Central Venous Pressure (CVP)
- Transthoracic echocardiography — PROCEDUREat Day 0 assessment of cardiac function
- Blood Sample Analysis — BIOLOGICALAt Day0: To assess baseline organ function that may impact participant safety, and blood samples for clinical laboratory tests
Study Details
This is a pivotal, global, prospective, cross-sectional, multicentric clinical investigation designed to explore a non-invasive, reliable alternative to invasive, catheter-based hemodynamic assessments, which are associated with procedural risks and limited applicability in certain participant populations.
Key Dates
- Start date
- Jan 15, 2026
- Status verified
- Oct 2025
- Primary completion
- Dec 31, 2026
- Completion
- Jan 15, 2027
Study Design
- Enrollment
- 149 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- DIAGNOSTIC
Arms
- Experimental: Full CohortThis population will be defined by patients fulfilling all inclusion and exclusion criteria.
Primary Outcome Measure
Proportion of individuals with elevated CVP (>10 mm Hg) who are correctly identified by LSM (cutoff of 13.3 kPa) [Sensitivity] [ Time Frame: at Day 0 ]
Central Contacts
- CAROLE MEILLEROUX, PharmD+33622649277
Locations (4)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Keck Medicine of USC-Norris Healthcare Center - Transplant Clinic | Los Angeles | California | 90033 | Michael Fong, MD |
| University of Minnesota | Minneota | Minnesota | 55455 | |
| Medical University of South Carolina | Charleston | South Carolina | 29425 | |
| University of Texas Southwestern Medical Center - Clinical Heart and Vascular Center - West Campus Building 3 Location | Dallas | Texas | 75390 |
Find similar trials in Los Angeles, CA
By condition
By specialty
By research site
Keck Medicine of USC-Norris Healthcare Center - Transplant Clinic· Los Angeles, CAUniversity of Minnesota· Minneota, MNMedical University of South Carolina· Charleston, SCUniversity of Texas Southwestern Medical Center - Clinical Heart and Vascular Center - West Campus Building 3 Location· Dallas, TX
Related Studies
- Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy ProductsRecruiting · Medtronic · Birmingham, Alabama
- Identification of Genomic Predictors of Adverse Events After Cardiac SurgeryRecruiting · Brigham and Women's Hospital · Boston, Massachusetts
- Get With The Guidelines-Heart Failure RegistryRecruiting · American Heart Association · Dallas, Texas
- Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by AnthracyclinesPHASE1 · Recruiting · M.D. Anderson Cancer Center · Houston, Texas